Prostate Cancer

Treatment

What are the existing treatment options for prostate cancer?

The stage of prostate cancer determines the prescribed treatment. There are three curative treatment modalities for prostate cancer.

  • A radical prostatectomy utilising the da Vinci® surgical system or by open tecnique is performed for early stage 1 and 2 cancers.
  • Radiation therapy in the form of external beam radiation using a linear accelerator is another form of treatment.. This treatment takes place over five continuous weeks for five days each week with a total of twenty-five treatments.
  • Another form of radiation therapy, which is a low-dose-rate prostate brachytherapy treatment, involves surgically implanting radioactive seeds in the prostate. Prostate brachytherapy is a day procedure, and the radioactivity period lasts a year. Seed implantation is permanent.

Triple therapy, which consists of three arms, is used for advanced prostate cancer and includes the following:

  • The first arm consists of prostate brachytherapy.
  • The second arm consists of five weeks of external beam radiation (for prostate cancer that spreads to the pelvic lymph nodes) that the doctors initiate a month following brachytherapy.
  • The third arm refers to hormonal castration therapy, which involves administering injections three monthly for a total period of nine months or two years, depending on the prostate cancer profile.

If you have concerns about prostate cancer or need more information, please don't hesitate to contact our practice. Our experienced team is here to provide you with comprehensive care and support.

Treatment FAQ

1. What are the main treatment options for prostate cancer?

Treatment options include active surveillance, surgery (radical prostatectomy), radiation therapy, hormone therapy, chemotherapy, immunotherapy, and targeted therapy. The choice of treatment depends on the stage and grade of the cancer, as well as the patient's overall health and preferences.


2. How is the best treatment plan determined for each patient?

The best treatment plan is individualised based on the cancer's stage and grade, the patient's age, overall health, potential side effects, and personal preferences. A multidisciplinary team often collaborates to tailor the best approach for each patient.


3. What is active surveillance, and when is it recommended?

Active surveillance involves closely monitoring prostate cancer without immediate treatment. It is recommended for patients with a low-risk, slow-growing cancer that is not causing symptoms. Regular PSA tests, digital rectal exams, and biopsies are conducted to monitor the cancer.


4. How often should patients undergo follow-up care after treatment?

Follow-up care typically includes regular PSA tests, physical exams, and imaging studies if necessary. The frequency depends on the initial stage of cancer and the type of treatment received, generally ranging from every three to six months initially, then annually after five years if no recurrence is detected.

Dr Frank Harry Bonfils-Persson, Dr Mark Purdy and Dr Heinrich Voigt,
the three specialist doctors at the Vaal Prostate Brachytherapy Institute, diagnose,
manage and treat prostate cancer, one of the most curable cancers.

CONTACT US